MSc in Cancer and Therapeutics in London United Kingdom | Queen Mary University of London

This program provides essential training in molecular and cellular biology, forming the basis for cancer biology and research. You'll explore cutting-edge advancements in cancer treatment, including innovative medications and genetic therapies, while learning how new treatments are created, tested, and applied. This MSc is also open to intercalating MBBS students. Taught by leading specialists from Barts Cancer Institute—a key member of the Cancer Research UK City of London Centre, a globally recognized hub for cancer biotherapeutics—the program offers flexible part-time study options to balance with your commitments. Gain a strong foundation in cancer therapy while pursuing specialized interests, along with extensive training in research methodologies. This degree serves as a career accelerator, teaching you to design and implement novel treatments. What you'll study This MSc provides in-depth knowledge of the scientific foundations behind cancer therapies. You'll learn how emerging treatments are designed, assessed, and introduced. Upon completion, you'll possess comprehensive understanding of cancer biology, pathology, research techniques, pharmaceutical development, and regulatory frameworks. The program strengthens your expertise in evaluating cancer treatments, improving career opportunities in cancer research, including early-stage clinical trials. Additionally, you'll undertake a three-month dissertation supervised by our research leaders, potentially involving a simulated clinical trial to gain hands-on experience in cancer-related clinical research and drug development. The program is delivered by Barts Cancer Institute, a Cancer Research UK Centre of Excellence and partner in the Cancer Research UK City of London Centre.